1. Home
  2. ABCL vs MCB Comparison

ABCL vs MCB Comparison

Compare ABCL & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • MCB
  • Stock Information
  • Founded
  • ABCL 2012
  • MCB 1999
  • Country
  • ABCL Canada
  • MCB United States
  • Employees
  • ABCL N/A
  • MCB N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • MCB Major Banks
  • Sector
  • ABCL Health Care
  • MCB Finance
  • Exchange
  • ABCL Nasdaq
  • MCB Nasdaq
  • Market Cap
  • ABCL 895.0M
  • MCB 722.4M
  • IPO Year
  • ABCL 2020
  • MCB 2017
  • Fundamental
  • Price
  • ABCL $2.68
  • MCB $60.00
  • Analyst Decision
  • ABCL Buy
  • MCB Buy
  • Analyst Count
  • ABCL 3
  • MCB 4
  • Target Price
  • ABCL $8.50
  • MCB $71.00
  • AVG Volume (30 Days)
  • ABCL 2.4M
  • MCB 77.5K
  • Earning Date
  • ABCL 11-04-2024
  • MCB 01-16-2025
  • Dividend Yield
  • ABCL N/A
  • MCB N/A
  • EPS Growth
  • ABCL N/A
  • MCB 8.87
  • EPS
  • ABCL N/A
  • MCB 5.34
  • Revenue
  • ABCL $32,962,000.00
  • MCB $258,166,000.00
  • Revenue This Year
  • ABCL N/A
  • MCB N/A
  • Revenue Next Year
  • ABCL $36.56
  • MCB $7.14
  • P/E Ratio
  • ABCL N/A
  • MCB $12.34
  • Revenue Growth
  • ABCL N/A
  • MCB 3.52
  • 52 Week Low
  • ABCL $2.34
  • MCB $32.46
  • 52 Week High
  • ABCL $6.06
  • MCB $69.56
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 44.26
  • MCB 50.52
  • Support Level
  • ABCL $2.76
  • MCB $62.73
  • Resistance Level
  • ABCL $3.05
  • MCB $66.34
  • Average True Range (ATR)
  • ABCL 0.16
  • MCB 2.42
  • MACD
  • ABCL -0.03
  • MCB -0.56
  • Stochastic Oscillator
  • ABCL 0.00
  • MCB 22.65

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: